Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Clinical Nuclear Medicine|April 8, 2016
SUV Normalized by Skeletal Volume on 18F-Fluoride PET/CT StudiesGiovanna Carvalho, José Flávio Gomes Marin, Alexandre Teles Garcez, et al.Journal of Visualized Experiments : Jove|March 15, 2021
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple SclerosisDaniele de Paula Faria, Caroline Cristiano Real, Larissa Estessi de Souza, et al.Radiologia Brasileira|March 24, 2015
Dose calibrator linearity test: (99m)Tc versus (18)F radioisotopesJosé Willegaignon, Marcelo Tatit Sapienza, George Barberio Coura-Filho, et al.Clinics (Sao Paulo, Brazil)|January 23, 2008
Effect of intertrochanteric osteotomy on the proximal femur of rabbits: assessment with power Doppler sonography and scintigraphyAndrea S Doria, Fabiano G Cunha, Marcelo Modena, et al.Amino Acids|November 24, 2015
Evaluation of GX1 and RGD-GX1 peptides as new radiotracers for angiogenesis evaluation in experimental glioma modelsÉrica Aparecida de Oliveira, Bluma Linkowski Faintuch, Roselaine Campos Targino, et al.American Journal of Physiology. Heart and Circulatory Physiology|May 21, 2016
The contributions of dipeptidyl peptidase IV to inflammation in heart failureThiago de Almeida Salles, Camila Zogbi, Thais Martins de Lima, et al.Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|November 24, 2022
Evaluation of 10-minute post-injection 11C-PiB PET and its correlation with 18F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer's diseaseCamila de Godoi Carneiro, Daniele de Paula Faria, Artur Martins Coutinho, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 15, 2020
Brain PET amyloid and neurodegeneration biomarkers in the context of the 2018 NIA-AA research framework: an individual approach exploring clinical-biomarker mismatches and sociodemographic parametersArtur Martins Coutinho, Geraldo F Busatto, Fábio Henrique de Gobbi Porto, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 28, 2020
Correction to: Brain PET amyloid and neurodegeneration biomarkers in the context of the 2018 NIA-AA research framework: an individual approach exploring clinical-biomarker mismatches and sociodemographic parametersArtur Martins Coutinho, Geraldo F Busatto, Fábio Henrique de Gobbi Porto, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 11, 2021
<i>In vivo</i> imaging evidence of poor cognitive resilience to Alzheimer's disease pathology in subjects with very low cognitive reserve from a low-middle income environmentGeraldo F Busatto, Fabio Henrique de Gobbi Porto, Daniele de Paula Faria, et al.Pageof 1